COMPUTATIONAL BIOLOGY AND CHEMISTRY
Scope & Guideline
Pioneering Solutions for Tomorrow’s Biological Challenges with Computational Techniques
Introduction
Aims and Scopes
- Computational Drug Design:
Research in this area emphasizes the use of computational methods for the design and optimization of small molecules and biologics, particularly in drug discovery and development. - Bioinformatics and Genomics:
This scope covers the application of computational tools to analyze biological data, including genomic sequences, transcriptomic data, and proteomics, facilitating the identification of biomarkers and therapeutic targets. - Molecular Dynamics and Simulations:
The journal publishes studies that utilize molecular dynamics simulations to understand the behavior of biomolecules and their interactions, providing insights into mechanisms of action and stability. - Machine Learning and AI in Biology:
The integration of machine learning and artificial intelligence techniques into biological research to enhance predictive modeling, classification, and data analysis is a prominent focus. - Systems Biology and Network Analysis:
Research that explores biological systems through the lens of network theory, including the interactions between genes, proteins, and metabolites, is a core area of interest. - Structural Bioinformatics:
Studies that involve the computational analysis of protein structures, interactions, and dynamics to elucidate functional mechanisms and design inhibitors.
Trending and Emerging
- Integrative Omics Approaches:
Recent publications highlight the trend of using multi-omics data integration (genomics, proteomics, metabolomics) to uncover complex biological insights and therapeutic targets. - Deep Learning Applications:
There is a significant increase in the use of deep learning techniques for various applications, including protein structure prediction, drug discovery, and biomarker identification. - Network Pharmacology:
The field of network pharmacology is gaining traction, with studies focusing on understanding the interactions between drugs and biological networks, enabling more holistic drug development strategies. - Artificial Intelligence in Drug Repurposing:
The use of AI to identify existing drugs for new therapeutic applications is increasingly prevalent, reflecting a shift towards more efficient drug development processes. - Computational Metabolomics:
Emerging research in computational metabolomics is gaining attention, focusing on the analysis of metabolic pathways and their implications in health and disease. - Structural Bioinformatics with AI:
A growing trend is the application of AI to assist in structural bioinformatics, particularly in predicting protein-ligand interactions and understanding protein folding.
Declining or Waning
- Traditional QSAR Studies:
Quantitative Structure-Activity Relationship (QSAR) studies, once a staple in computational chemistry, have seen reduced emphasis as more advanced machine learning techniques gain popularity for predictive modeling. - Single-Method Approaches:
There is a noticeable decline in publications focusing solely on one computational method, as interdisciplinary approaches combining multiple methodologies are becoming preferred. - Basic Molecular Docking Studies:
Basic studies on molecular docking without incorporating advanced techniques or extensive validation have become less prevalent, as the field moves towards more integrated and robust computational frameworks. - In Vitro Validation Studies:
While still relevant, the frequency of papers that solely focus on in vitro validation of computational predictions without substantial computational contributions has decreased.
Similar Journals
IEEE-ACM Transactions on Computational Biology and Bioinformatics
Catalyzing Progress in Applied Mathematics, Biotechnology, and GeneticsIEEE-ACM Transactions on Computational Biology and Bioinformatics is a prestigious journal published by the IEEE Computer Society, focusing on the interdisciplinary field of computational biology and bioinformatics. Established in 2004, this journal has made significant strides in contributing to our understanding of complex biological systems through quantitative methods and computational techniques, and it spans a converged publication period through 2024. As a notable resource with an impact factor that positions it in the second quartile in the domains of Applied Mathematics, Biotechnology, and Genetics, it serves as an essential platform for researchers and professionals seeking to disseminate their findings to a global audience. The journal ranks impressively in Scopus, with Applied Mathematics holding a rank of #38 out of 635 (94th percentile) and Genetics at #86 out of 347 (75th percentile), highlighting its significant influence in the scientific community. While the journal is not open-access, it provides valuable insights and cutting-edge research that are crucial for advancing the fields of bioinformatics and computational biology, making it indispensable for students, researchers, and practitioners alike.
Molecular Systems Biology
Advancing the Frontiers of Biological ScienceMolecular Systems Biology, published by SpringerNature, is a premier open access journal that has been a cornerstone in advancing the fields of biological science since its inception in 2005. With its ISSN 1744-4292, this journal exemplifies high scholarly standards, boasting an impressive suite of impact factors, including Q1 rankings across various disciplines such as Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, and more, highlighting its significant contribution to the scientific community. The journal offers robust access options to facilitate innovative research dissemination, reaching a global audience while maintaining a commitment to fostering collaboration and dialogue among researchers, professionals, and students. With a focus on integrating quantitative approaches to biological systems, Molecular Systems Biology plays a vital role in addressing complex biological questions, paving the way for groundbreaking discoveries and advancements in healthcare, environmental sustainability, and functional genomics.
JOURNAL OF COMPUTATIONAL BIOLOGY
Innovating Insights at the Intersection of Biology and TechnologyJOURNAL OF COMPUTATIONAL BIOLOGY, published by Mary Ann Liebert, Inc., serves as a premier platform for the dissemination of groundbreaking research at the intersection of biological sciences and computational methods. Established in 1994, this journal provides a valuable resource for researchers, professionals, and students interested in the evolving fields of computational mathematics and biology. With a commendable Q2 ranking in several pertinent categories such as Computational Mathematics and Modeling and Simulation, it emphasizes high-quality studies that propel understanding and innovation in these areas. Although the journal currently operates under traditional access options, it plays a crucial role in fostering scholarly communication and collaboration among a diverse audience, advancing knowledge in genetics, molecular biology, and beyond. The journal's continual evolution, with a commitment to publish until at least 2024, positions it as a critical resource in the fast-paced world of computational biology.
Chemical Biology & Drug Design
Bridging theory and practice in chemical biology and pharmacology.Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.
npj Systems Biology and Applications
Unveiling New Dimensions in Biological Systemsnpj Systems Biology and Applications, published by NATURE PORTFOLIO, is a premier open-access journal that has been at the forefront of the field since its inception in 2015. With a commendable focus on the interdisciplinary integration of applied mathematics, biochemistry, computer science, and drug discovery, the journal currently enjoys a Q1 ranking across multiple categories, showcasing its significant impact within the scientific community. In 2023, it ranked 70 out of 635 in Applied Mathematics and holds a notable place in the 89th percentile, confirming its esteemed reputation among researchers. Situated in the United Kingdom, this journal not only promotes innovative research in systems biology but also serves as an essential platform for the dissemination of high-quality studies that delve into modeling, simulation, and the application of biological systems in drug discovery processes. With an open-access model, authors can reach a broad audience, enhancing collaborations and advancing knowledge across disciplines, making it an indispensable resource for researchers, professionals, and students alike seeking to contribute to the evolving landscape of systems biology.
Chem-Bio Informatics Journal
Exploring the Intersection of Informatics and Life SciencesChem-Bio Informatics Journal is a dedicated platform for the dissemination of innovative research in the intersecting realms of biochemistry and computational science. Published by the CHEM-BIO INFORMATICS SOC in Japan, this journal embraces the rapidly evolving field of chemoinformatics and bioinformatics, fostering scholarly communication among researchers, professionals, and students alike. With its ISSN: 1347-6297 and E-ISSN: 1347-0442, the journal continues to enrich the scientific community by offering insights into novel methodologies and applications that bridge chemistry and biology. Although currently positioned in the fourth quartile in the biochemistry category according to Scopus rankings, contributing to this journal provides an invaluable opportunity for authors to showcase impactful findings that could resonate within the field. The journal is particularly committed to supporting interdisciplinary research that addresses complex biological problems through computational modeling and data analysis. By publishing high-quality and peer-reviewed articles, Chem-Bio Informatics Journal aims to enhance the scientific discourse and is poised to become a pivotal resource for advancing the frontiers of biochemistry and molecular biology.
Molecular Informatics
Catalyzing Innovation in Structural Biology and Drug DevelopmentMolecular Informatics is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the fields of computational analysis and molecular modeling. As a key resource in the realms of Computer Science Applications, Drug Discovery, Molecular Medicine, Organic Chemistry, and Structural Biology, this journal is recognized for its significant contributions and is ranked in the Q2 and Q3 categories across multiple disciplines, positioning it among the leading journals for researchers and academics. With an impressive track record since its inception in 2010 and converging its contributions until 2024, Molecular Informatics aims to bridge the gap between computational techniques and biological applications, promoting interdisciplinary collaboration and innovation. Accessible to a global audience, the journal reflects a commitment to advancing science through open access options, making cutting-edge research available to students, professionals, and decision-makers alike. This journal serves as an indispensable platform for disseminating high-quality research and fostering the development of new theoretical and practical frameworks in molecular informatics.
Current Bioinformatics
Innovating Computational Techniques for Biological InsightsCurrent Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.
Journal of Bioinformatics and Computational Biology
Innovating Solutions for Complex Biological ChallengesThe Journal of Bioinformatics and Computational Biology, published by WORLD SCIENTIFIC PUBL CO PTE LTD, serves as a significant platform for disseminating innovative research in the dynamic fields of bioinformatics and computational biology. With an ISSN of 0219-7200 and an E-ISSN of 1757-6334, this journal facilitates the exchange of ideas and advancements from its inception in 2003 and continues to be pivotal through 2024. Despite its classification in the lower quartiles—Q4 in Biochemistry and Q4 in Molecular Biology, along with Q3 in Computer Science Applications—the journal remains a valuable resource for researchers and students alike, as it emphasizes interdisciplinary approaches essential for tackling complex biological problems through computational methods. Located in Singapore, the journal encourages submissions of high-quality, peer-reviewed articles that offer insights into computational techniques that empower biological research. Although this journal does not offer open access options, its contributions to research are increasingly recognized across various academic platforms. As the field evolves rapidly, this journal continues to attract a growing readership, making it an essential reference point for anyone interested in the intersection of biology and computer science.
Frontiers in Bioinformatics
Connecting Ideas, Driving Innovation in BioinformaticsFrontiers in Bioinformatics is a leading academic journal dedicated to advancing the field of bioinformatics by publishing high-quality research and review articles. Published by FRONTIERS MEDIA SA, this open-access journal aims to foster innovative research, promote collaborative initiatives, and provide a platform for the dissemination of findings related to computational biology, biostatistics, and the intersection of bioinformatics with other biological disciplines. With a focus on promoting accessibility and visibility of research, Frontiers in Bioinformatics operates under a rigorous peer-review process, ensuring that all published content meets the highest academic standards. The journal has shown a commendable rank across various Scopus categories, including Mathematics, Computational Mathematics, and multiple dimensions of Biochemistry and Molecular Biology, indicating its relevance and impact within the research community. Researchers, professionals, and students will find this journal invaluable for staying abreast of the latest developments and breakthroughs in bioinformatics, enhancing their studies and professional projects.